Exelixis (EXEL) Beats Q3 Estimates, Is The Stock Fully Priced?

October 31, 2026 - 12:13

Exelixis (EXEL) is back in focus after its third quarter 2026 earnings, where revenue reached US$658.7 million and net income came in at US$218.1 million, both above last year's levels. The earnings beat and steady 2026 guidance reset the tone around Exelixis, with the share price up 4.82% on the day and a 30 day share price return of 18.80%, contributing to a 59.22% year to date move. The 5 year total shareholder return of 258.42% shows how long term holders have already been rewarded even before this latest quarter.

The question now is whether the stock still has room to run or whether the recent rally has already captured the good news. Revenue growth and profitability both look solid, and the company's guidance suggests management expects the momentum to continue. But after a year to date gain of nearly 60%, some investors may wonder if the easy money has been made.

Valuation matters here. A stock that has climbed this far this fast tends to price in a lot of optimism, and any stumble in upcoming quarters could hit shares hard. At the same time, the earnings beat and raised confidence give bulls a reason to stay. For now, Exelixis looks like a company delivering on its numbers, with the market left to decide how much more it is willing to pay for that performance.